Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
R3H domain containing like (R3HDML) is a protein coding gene that encodes a cysteine-rich, secreted protein predicted to act as a peptidase inhibitor and to bind nucleic acids via its R3H domain[6][1][7]. R3HDML is expressed during skeletal muscle development and regeneration, where it is secreted by satellite cells and is essential for muscle regeneration and myogenic cell differentiation; reduced expression impairs these processes in mouse models[2]. In the kidney, R3HDML is expressed in podocytes, where it acts to inhibit TGF-β-induced p38 MAPK activation, suppressing apoptosis and providing protection during diabetic nephropathy in mice[5]. Its molecular functions include roles as a putative serine protease inhibitor as well as involvement in nucleic acid and polynucleotide binding, likely through the R3H domain, which is conserved and hypothesized to contribute to interactions with single-stranded nucleic acids[1][7][6]. No approved drugs, clinical biomarkers, or safety concerns are currently linked directly to R3HDML.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on R3H domain containing like (R3HDML).